(Q39439735)

12 September 2017

title

Efficacy of nebulized ipratropium in severely asthmatic children (English)

1 reference

12 September 2017

0 references

Qureshi F

1

1 reference

12 September 2017

Zaritsky A

series ordinal

2

1 reference

12 September 2017

Lakkis H

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

Annals of Emergency Medicine

12 September 2017

published in

1 reference

12 September 2017

volume

29

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

205-211

1 reference

How the current understanding of the pathophysiology of asthma influences our approach to therapy

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Ventilatory functions of normal children and young adults—Mexican-American, white, and black. I. Spirometry

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Anticholinergic, Antimuscarinic Bronchodilators1,2

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Inhaled Atropine Sulfate in Acute Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

1 reference

7 January 2021

Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Dose of nebulized ipratropium bromide in acute severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Use of ipratropium bromide in asthma. Results of a multi-clinic study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Paradoxical bronchoconstriction in wheezing infants after nebulised preservative free iso-osmolar ipratropium bromide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Acute angle-closure glaucoma as a complication of combined beta-agonist and ipratropium bromide therapy in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Salbutamol versus atropine. Site of bronchodilatation in asthmatic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Site of action of ipratropium bromide and clinical and physiological determinants of response in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Bronchodilating effect of ipratropium bromide inhalation powder and aerosol in children and adolescents with stable bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Ipratropium bromide in acute asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Nebulized ipratropium in the treatment of acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Salbutamol and ipratropium in acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Nebulised ipratropium and salbutamol in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Comparison of ipratropium solution, fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970269-5

7 January 2021

10.1016/S0196-0644(97)70269-5

Identifiers

DOI

1 reference

12 September 2017

1 reference